PHARMA NORD EXPORT ApS: Financial statements 2024
CVR: 70996510
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PHARMA NORD EXPORT ApS (CVR 70996510) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,331,908 and a net result of DKK 6,889,205 compared with DKK 6,301,578 the year before. That is a decrease of 7.6% compared with the year before. Equity in the 2024 report amounted to DKK 44,178,384. The solvency ratio was 59.7%. The company had 77 employees in the financial year.
- Gross Profit
- DKK 1,331,908
- Profit/Loss
- DKK 6,889,205
- Equity
- DKK 44,178,384
- Total Assets
- DKK 74,058,335
- Employees
- 77
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.3 mio. | 6.9 mio. | 44.2 mio. | 77 |
| 2023 | - | 1.4 mio. | 6.3 mio. | 37.4 mio. | 65 |
| 2022 | - | 1.6 mio. | 2.1 mio. | 46 mio. | 63 |
| 2021 | - | 1.7 mio. | 3.2 mio. | 43.9 mio. | 49 |
| 2020 | - | 2.2 mio. | 2.7 mio. | 40.8 mio. | 48 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PHARMA NORD EXPORT ApS has published its annual report for 2023. Gross profit came to DKK 1,442,161, and the net result was DKK 6,301,578.
About PHARMA NORD EXPORT ApS
PHARMA NORD EXPORT ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1982. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named TRAUDE SCHNEIDER ASTROFAKTA-DANMARK ApS. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO II ApS and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK 1,575,000 and a net result of DKK 11,516,000 compared with DKK 6,889,205 the year before. Equity in the 2025 report amounted to DKK 46,928,000.